TRANSGENE (EPA:TNG) | Finanzwire

Basculer en Français

10036	Companies
204447	Keywords
134794	Articles
108446	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 08/27/2024 at 07:30, 1 year 6 months ago

Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 published in JITC
Transgene announces preclinical proof-of-concept data of oncolytic virus TG6050 published in JITC, showcasing tumor regression and immune remodeling capabilities without systemic toxicity. TG6050 progressing in Phase I trial for NSCLC

Phase I Trial Transgene Oncolytic Virus TG6050 JITC Publication
BRIEF

published on 07/30/2024 at 21:06, 1 year 7 months ago

Transgene consolidates its balance sheet thanks to the conversion of part of the advance into shares

Biotechnology Immunotherapy Increase In Capital Transgene Mérieux Institute
BRIEF

published on 06/03/2024 at 07:35, 1 year 9 months ago

Transgene includes the first patient in Phase II of the study of its TG4050 vaccine against head and neck cancers

Head And Neck Cancer Transgene TG4050 Phase II Therapeutic Vaccine
PRESS RELEASE

published on 06/03/2024 at 07:30, 1 year 9 months ago

Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
Transgene enrolls first patient in Phase II of randomized Phase I/II trial for cancer vaccine TG4050 in head and neck cancer, with completion expected in Q4 2025

Phase II Trial Head And Neck Cancer Cancer Vaccine Transgene TG4050
BRIEF

published on 05/14/2024 at 17:50, 1 year 10 months ago

Transgene Announces Positive Q1 2024 Update and Future Clinical Milestones

Clinical Trials Financial Update Cancer Immunotherapy Transgene TG4050
PRESS RELEASE

published on 05/14/2024 at 17:45, 1 year 10 months ago

Transgene provides business and financial update for Q1 2024
Transgene provides business and financial update for Q1 2024, including promising Phase I data on TG4050 and upcoming clinical data expectations on TG4001, TG6050, and BT-001 in H2 2024

Clinical Data Q1 2024 Financial Update Transgene TG4050

Accesswire

Published on 03/16/2026 at 19:55, 1 hour 14 minutes ago

GGL Resources Corp. Updates the Status of its Earn-In Agreement on its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/16/2026 at 18:12, 2 hours 57 minutes ago

Sekur Private Data Signs Distribution Agreement In Africa
Published on 03/16/2026 at 14:00, 7 hours 9 minutes ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
Published on 03/16/2026 at 13:45, 7 hours 24 minutes ago

iFabric Corp Provides Strong 2025 Revenue Estimate and 2026 Outlook
Published on 03/16/2026 at 13:30, 7 hours 39 minutes ago

Ondas Completes Acquisition of Rotron Aerospace Ltd., Expanding Long-Range Propulsion Technologies for Advanced Unmanned Systems for Defense

View all ACCESSWIRE

EQS Group

Published on 03/16/2026 at 20:53, 15 minutes ago

EQS-Adhoc: EPH Group AG: Extension of Alexander Lühr’s Executive Board contract; appointment of an additional Executive Board member
Published on 03/16/2026 at 19:50, 1 hour 19 minutes ago

EQS-Adhoc: Softing AG approves 10% cash capital increase excluding subscription rights
Published on 03/16/2026 at 19:45, 1 hour 24 minutes ago

EQS-Adhoc: Northern Data Announces FY 2025 preliminary Financial Results
Published on 03/16/2026 at 19:24, 1 hour 44 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/16/2026 at 18:45, 2 hours 23 minutes ago

Cognizant Expands AI Infrastructure Capabilities with Launch of Cognizant AI Factory

Les Echos

Published on 03/16/2026 at 18:00, 3 hours 9 minutes ago

Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 3 hours 11 minutes ago

Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 3 hours 12 minutes ago

Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:45, 3 hours 24 minutes ago

Weekly share buyback
Published on 03/16/2026 at 17:35, 3 hours 34 minutes ago

Disclosure of transactions in own shares from March 9 to March 13, 2026

View all LES ECHOS COMFI WIRE